Stock Events

Stock Events

Halozyme Therapeutics (RV7.F) Q4 2024 Earnings

31OctConfirmed

Q1 2024

Q2 2024

Q3 2024

Q4 2024

0.64

0.81

0.99

1.17

Details

Expected EPS

0.9106613749999999

Actual EPS

1.166749

Surprise EPS

0.26

Surprise Percent

+28.12%

Description

Halozyme Therapeutics (RV7.F) has reported earnings of 1.166749 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.